Tumor Ablation Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

The global Tumor Ablation market size is expected to be worth around US$ 2.9 billion by 2030, according to a new report by Vision Research Reports.

The global Tumor Ablation market size was valued at US$ 660.5 million in 2020 and is anticipated to grow at a CAGR of 13.8% during forecast period 2021 to 2030.

Growth Factors

The increasing incidence of cancer and high demand for effective treatment options are the major factors driving the market growth. According to Cancer Research U.K., the incidence rate of cancer is expected to grow by 62.0% from 2018 to 2040. Lung, breast, bowel, and prostate are the most common sites reported with cancer in 2018.

Increasing inclination towards minimally invasive procedures owing to benefits such as speedy recovery, patient comfort, and shorter turnaround time are the factors expected to foster the demand for advanced tumor ablation techniques during the forecast period. Integration of tumor ablation devices with efficient interventional imaging modalities such as ultrasound, and CT is anticipated to revolutionize ablation procedures performed in outpatient settings. This is expected to significantly eliminate the cost to the patient including hospital stays.

Supportive government initiatives such as screening programs, awareness campaigns, and cancer schemes for various cancer types are expected to increase the number of diagnosed cases. For instance, in 2019, the National Health Scheme (NHS) started offering lung cancer screening programs in some areas of England. Such initiatives are anticipated to escalate the need for cancer management in the early cancer stages, thereby driving the market.

Report Highlights

The radiofrequency tumor ablation technology segment dominated the market for tumor ablation and accounted for the largest revenue share of 35.4% in 2020. The dominance can be attributed to its advantages such as specificity and efficiency in solid tumor ablation procedures in the kidney and liver. Additionally, radiofrequency ablation can be used to treat multiple tumors at the same time, thus improving procedural efficiency with the use of multiple electrodes placed at different sites. This is expected to boost the adoption rate of advanced tumor ablation techniques.

The success rate of radiofrequency/microwave ablation technology in eliminating small liver tumors is estimated to be greater than 85.0%. According to the NCBI report, the recurrence of tumors in patients opting for surgical resection ranges from 30.0% to 70.0%. On the other hand, tumor recurrence is very low (0.7-8%) in cases of radiofrequency ablation for similar tumors. Advantages of radiofrequency techniques to successfully treat tumors at early stages are expected to drive the market for tumor ablation during the forecast period.

The liver cancer segment dominated the market for tumor ablation and accounted for the largest revenue share of nearly 19.9% in 2020. This can be attributed to the rising incidence of bile duct cancer as well as primary liver cancer. Based on application, the market is segmented into kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, and others. Other segment includes various types of cancer such as bone metastasis and ENT cancer. The availability of advanced methods and increasing cancer prevalence are anticipated to facilitate market growth.

The surgical ablation segment dominated the market for tumor ablation and accounted for the largest revenue share of 40.3% in 2020. Increased prevalence of liver and breast cancer and unavailability of advanced tumor ablation techniques for these particular organs are the factors estimated to fuel the segment growth. The percutaneous ablation segment is expected to exhibit lucrative growth over the forecast period. These procedures offer faster recovery, minimal scarring, and increased safety. In addition, factors such as quick surgery time, patient comfort, and cost-efficiency are anticipated to further boost the segment demand. However, higher complications associated with the system are anticipated to limit its growth, especially in hospitals lacking skilled professionals. 

According to the NCBI report, percutaneous ablations are not feasible in about 25-55% of patients due to unfavorable tumor locations. The tumor recurrence rate is higher in percutaneous ablation, due to insufficient ablation of the tumors located deep inside the tissue. Additionally, percutaneous ablation is contraindicated in treating lesions that are very adjacent to the gastrointestinal tract, gall bladder, bile duct, and heart due to a high risk of tumor recurrence. Therefore, in such a case, laparoscopic ablation is efficient in providing long-term outcomes while simultaneously retaining minimal invasiveness. This is expected to boost the laparoscopic ablation segment growth during the forecast period.

North America dominated the tumor ablation market and accounted for the largest revenue share of 34.3% in 2020. Major factors contributing to the growth of this region include government support for quality healthcare, high purchasing power parity, availability of reimbursements, and increasing prevalence of cancer. For instance, in the U.S., the Patient Protection and Affordable Care Act (PPACA) promotes the quality and affordability of health care through health coverage policies, which reduces the cost of healthcare for individuals and the government. In addition, the precision medicine initiative in formulating tailored strategies on unique characteristics of diseases. Hence, such government initiatives are anticipated to improve the overall healthcare system, thus boosting the market growth.

Europe followed North America in terms of revenue share in 2020. A greater extent of public funding in Europe’s healthcare system has contributed to this growth. Moreover, the growing geriatric population coupled with government support to control cancer is estimated to boost the market growth in this region. For instance, the European Cancer Observatory aims to create awareness about cancer, early diagnostic techniques, and advanced, minimally invasive therapeutic options.

Key Players

  • Galil Medical Inc.

  • Misonix Inc.

  • HealthTronics

  • Mermaid Medical

  • Theraclion

  • Chongqing Haifu Medical Technology Co., Ltd.

  • HS Hospital Service S.P.A

  • EDAP TMS S.A.

Market Segmentation

  • Technology Outlook 

    • Radiofrequency ablation

    • Microwave ablation

    • Cryoablation

    • Irreversible electroporation ablation

    • Other ablation technologies

  • Treatment Outlook

    • Surgical ablation

      • Kidney Cancer

      • Liver cancer

      • Breast cancer

      • Lung cancer

      • Prostate cancer

      • Other cancer

    • Laparoscopic ablation

      • Kidney Cancer

      • Liver cancer

      • Breast cancer

      • Lung cancer

      • Prostate cancer

      • Other cancer

    • Percutaneous ablation

      • Kidney Cancer

      • Liver cancer

      • Breast cancer

      • Lung cancer

      • Prostate cancer

      • Other cancer

  • Application Outlook 

    • Kidney Cancer

    • Liver cancer

    • Breast cancer

    • Lung cancer

    • Prostate cancer

    • Other cancer

  • Regional Outlook 

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

      • Russia

      • Netherland

      • Switzerland

      • Belgium

      • Hungary

    • Asia Pacific

      • China

      • Japan

      • India

      • Thailand

      • South Korea

      • Taiwan

      • Malaysia

      • Singapore

      • Indonesia

      • Philippines

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

      • Chile

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Turkey

      • Israel

The Tumor Ablation market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Tumor Ablation market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Tumor Ablation market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tumor Ablation market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Tumor Ablation market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Tumor Ablation capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Tumor Ablation by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Tumor Ablation market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Tumor Ablation market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Tumor Ablation market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Tumor Ablation industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

The Tumor Ablation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Tumor Ablation market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Tumor Ablation market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Tumor Ablation market. These factors have benefited the growth of the global market for Tumor Ablation. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Tumor Ablation. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Tumor Ablation are as follows:

  • Historic Year: 2017-2020
  • Base Year: 2021
  • Forecast Year 2021 to 2030

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

 In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Tumor Ablation Market, By Technology

7.1.  Tumor Ablation Market, By Technology Type, 2020-2030

7.1.1.    Radiofrequency ablation

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Microwave ablation

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Cryoablation

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Irreversible electroporation ablation

7.1.4.1.        Market Revenue and Forecast (2016-2030)

7.1.5.    Other ablation technologies

7.1.5.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Tumor Ablation Market, By Treatment

8.1.  Tumor Ablation Market, By Treatment, 2020-2030

8.1.1.    Surgical ablation

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Laparoscopic ablation

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Percutaneous ablation

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Tumor Ablation Market, Application

9.1.  Tumor Ablation Market, Application, 2020-2030

9.1.1.    Kidney Cancer

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Liver cancer

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Breast cancer

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    Lung cancer

9.1.4.1.        Market Revenue and Forecast (2016-2030)

9.1.5.    Prostate cancer

9.1.5.1.        Market Revenue and Forecast (2016-2030)

9.1.6.    Other cancer

9.1.6.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Tumor Ablation Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, By Technology (2016-2030)

10.1.2.  Market Revenue and Forecast, By Treatment (2016-2030)

10.1.3.  Market Revenue and Forecast, Application (2016-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.1.4.2.      Market Revenue and Forecast, By Treatment (2016-2030)

10.1.4.3.      Market Revenue and Forecast, Application (2016-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.1.5.2.      Market Revenue and Forecast, By Treatment (2016-2030)

10.1.5.3.      Market Revenue and Forecast, Application (2016-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, By Technology (2016-2030)

10.2.2.  Market Revenue and Forecast, By Treatment (2016-2030)

10.2.3.  Market Revenue and Forecast, Application (2016-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.2.4.2.      Market Revenue and Forecast, By Treatment (2016-2030)

10.2.4.3.      Market Revenue and Forecast, Application (2016-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.2.5.2.      Market Revenue and Forecast, By Treatment (2016-2030)

10.2.5.3.      Market Revenue and Forecast, Application (2016-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.2.6.2.      Market Revenue and Forecast, By Treatment (2016-2030)

10.2.6.3.      Market Revenue and Forecast, Application (2016-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.2.7.2.      Market Revenue and Forecast, By Treatment (2016-2030)

10.2.7.3.      Market Revenue and Forecast, Application (2016-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, By Technology (2016-2030)

10.3.2.  Market Revenue and Forecast, By Treatment (2016-2030)

10.3.3.  Market Revenue and Forecast, Application (2016-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.3.4.2.      Market Revenue and Forecast, By Treatment (2016-2030)

10.3.4.3.      Market Revenue and Forecast, Application (2016-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.3.5.2.      Market Revenue and Forecast, By Treatment (2016-2030)

10.3.5.3.      Market Revenue and Forecast, Application (2016-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.3.6.2.      Market Revenue and Forecast, By Treatment (2016-2030)

10.3.6.3.      Market Revenue and Forecast, Application (2016-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.3.7.2.      Market Revenue and Forecast, By Treatment (2016-2030)

10.3.7.3.      Market Revenue and Forecast, Application (2016-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, By Technology (2016-2030)

10.4.2.  Market Revenue and Forecast, By Treatment (2016-2030)

10.4.3.  Market Revenue and Forecast, Application (2016-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.4.4.2.      Market Revenue and Forecast, By Treatment (2016-2030)

10.4.4.3.      Market Revenue and Forecast, Application (2016-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.4.5.2.      Market Revenue and Forecast, By Treatment (2016-2030)

10.4.5.3.      Market Revenue and Forecast, Application (2016-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.4.6.2.      Market Revenue and Forecast, By Treatment (2016-2030)

10.4.6.3.      Market Revenue and Forecast, Application (2016-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.4.7.2.      Market Revenue and Forecast, By Treatment (2016-2030)

10.4.7.3.      Market Revenue and Forecast, Application (2016-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, By Technology (2016-2030)

10.5.2.  Market Revenue and Forecast, By Treatment (2016-2030)

10.5.3.  Market Revenue and Forecast, Application (2016-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.5.4.2.      Market Revenue and Forecast, By Treatment (2016-2030)

10.5.4.3.      Market Revenue and Forecast, Application (2016-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.5.5.2.      Market Revenue and Forecast, By Treatment (2016-2030)

10.5.5.3.      Market Revenue and Forecast, Application (2016-2030)

Chapter 11.  Company Profiles

11.1.              Galil Medical Inc.

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Misonix Inc.

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              HealthTronics

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Mermaid Medical

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Theraclion

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Chongqing Haifu Medical Technology Co., Ltd.

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              HS Hospital Service S.P.A

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              EDAP TMS S.A.

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers